IL18BP
Interleukin-18-binding protein
Also known as: I18BP_HUMAN, IL18BPa
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95998
- Gene
- IL18BP
- Ensembl
- ENSG00000137496
- Chromosome
- 11
- Canonical length
- 194 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene functions as an inhibitor of the proinflammatory cytokine, IL18. It binds IL18, prevents the binding of IL18 to its receptor, and thus inhibits IL18-induced IFN-gamma production, resulting in reduced T-helper type 1 immune responses. This protein is constitutively expressed and secreted in mononuclear cells. Elevated level of this protein is detected in the intestinal tissues of patients with Crohn's disease. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
194 residues, UniProt reviewed canonical sequence.
>O95998|IL18BP
1 MTMRHNWTPD LSPLWVLLLC AHVVTLLVRA TPVSQTTTAA TASVRSTKDP CPSQPPVFPA
61 AKQCPALEVT WPEVEVPLNG TLSLSCVACS RFPNFSILYW LGNGSFIEHL PGRLWEGSTS
121 RERGSTGTQL CKALVLEQLT PALHSTNFSC VLVDPEQVVQ RHVVLAQLWA GLRATLPPTQ
181 EALPSSHSSP QQQGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL18BP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- spleen: 44 nTPM
- lung: 29 nTPM
- kidney: 23 nTPM
- lymph node: 19 nTPM
- appendix: 19 nTPM
- adrenal gland: 17 nTPM
Single-cell type
- cardiomyocytes: 63 nCPM
- epicardial cells: 39 nCPM
- macrophages: 22 nCPM
- adipocytes: 20 nCPM
- kupffer cells: 17 nCPM
- vascular endothelial cells: 15 nCPM
Immune cell
- intermediate monocyte: 68 nTPM
- non-classical monocyte: 57 nTPM
- eosinophil: 53 nTPM
- plasmacytoid DC: 49 nTPM
- gdT-cell: 49 nTPM
- total PBMC: 36 nTPM
Brain region
- pons: 14 nTPM
- thalamus: 14 nTPM
- medulla oblongata: 13 nTPM
- hypothalamus: 13 nTPM
- cerebral cortex: 12 nTPM
- midbrain: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL18BP.
Disease | AllUniProt
Conditions IL18BP is implicated in, by any mechanism.
- Hepatitis, fulminant viral (FVH) MIM:618549
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.82
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.55
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hydrogen peroxide
- cellular response to tumor necrosis factor
- response to lipopolysaccharide
- T-helper 1 type immune response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin-like domain
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Interleukin-18-binding protein
- Interleukin-18-binding protein-like domain
- Yaba-Like Disease Virus IL18BP
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL18BP as an antibody target. Whether an autoantibody or antibody against IL18BP could matter depends on whether native IL18BP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL18BP is annotated as secreted, so native IL18BP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL18BP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...